"This has enabled us to i) re-commence the Depressive Burden trial; and ii) explore avenues for commercialisation of MEBsleep, in anticipation of FDA clearance."
This sentence tells all, FDA approval should be this week.
Ann: Medibio Quarterly Update and Cashflow Report, page-82
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TRI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.5¢ |
Change
-0.001(2.78%) |
Mkt cap ! $16.45M | |||
| Open | High | Low | Value | Volume |
| 3.6¢ | 3.6¢ | 3.4¢ | $15.83K | 465.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 164410 | 3.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.6¢ | 1084578 | 4 |
View Market Depth
| Last trade - 12.18pm 25/07/2024 (20 minute delay) ? |
| TRI (ASX) Chart |